title: Cross-boundary cancer studies at the University of Tokyo: Oncology in Asian countries: clinical development challenges and opportunities.
authors: please contact Hideyuki Akaza, MD, Department of Strategic Investigation on Comprehensive Cancer Network, Research Center for Advanced Science and Technology, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8904, Japan. akazah@med.rcast.u-tokyo.ac.jp.
authors: Pascal
authors: P
authors: Rigaudy
mesh_terms: D001208:Asia; D002681:China; D002986:Clinical Trials as Topic / Q000379:methods / Q000592:standards / Q000639:trends; D003695:Delivery of Health Care / Q000458:organization & administration / Q000592:standards / Q000639:trends; D017277:Drug Approval; D004345:Drug Industry; D006801:Humans; D015994:Incidence; D007391:International Cooperation; D007564:Japan / Q000453:epidemiology; D008495:Medical Oncology / Q000458:organization & administration / Q000592:standards / Q000639:trends; D009026:Mortality / Q000639:trends; D009369:Neoplasms / Q000188:drug therapy* / Q000453:epidemiology* / Q000401:mortality; D056910:Republic of Korea; D012107:Research Design
keywords: cancer in Asia; cancer treatment; cross-boundary cancer studies; drug development; the University of Tokyo